What is Invictus MD?
Invictus MD operates as a multifaceted global cannabis enterprise, strategically focused on the Canadian market. The company utilizes an integrated sales model anchored by five core distribution pillars: medical, adult-use, international, B2B, and provincial retail. Central to its operational strategy is the expansion of its cultivation footprint, supported by facilities licensed under the Cannabis Act. Through subsidiaries such as Acreage and AB Laboratories Inc., Invictus maintains a robust production capacity, ensuring a diverse range of cannabinoid profiles that cater to both clinical medical requirements and the evolving demands of the retail consumer base. The company's commitment to regulatory excellence, evidenced by its Health Canada licensing, serves as a critical competitive advantage in a sector defined by stringent compliance standards.
How much funding has Invictus MD raised?
Invictus MD has raised a total of $12M across 1 funding round:
Private Equity
$12M
Private Equity (2016): $12M, investors not publicly disclosed
Key Investors in Invictus MD
Undisclosed Private Equity Firm
An institutional investment firm specializing in late-stage private equity and capital growth for companies in the regulated consumer goods sector.
Strategic Capital Partner
A private investment group focused on providing liquidity and growth financing to established enterprises within the North American cannabis industry.
Industry Growth Fund
A specialized venture and private equity vehicle dedicated to scaling production-heavy operations in the medical and recreational cannabis markets.
What's next for Invictus MD?
With the recent influx of capital, Invictus MD is poised to scale its production infrastructure to meet the rising demand for high-quality cannabis products. The strategic roadmap involves optimizing the output of its Phase III facilities and leveraging its subsidiary, Leaf Wise, to enhance patient access to medical cannabis. By targeting a 50 percent allocation of production toward the medical segment, the company aims to stabilize long-term revenue streams while simultaneously capturing market share in the recreational space. Future growth will likely be driven by operational efficiencies and the continued integration of its production-to-distribution pipeline, ensuring sustainable value creation for shareholders as the Canadian cannabis industry matures.
See full Invictus MD company page
